Kidney Stones

Holmium laser advances help propel progress in BPH, urinary stones

August 05, 2020

Holmium laser lithotripsy with Moses 2.0 is intended to enhance precision and versatility by optimizing laser energy transmission.

Thulium fiber laser shows efficiency advantage in experimental setting

July 29, 2020

Super-pulsed thulium fiber laser (TFL) has greater efficiency than a holmium:YAG laser, even when using the TFL with a smaller core-diameter fiber, according to preclinical findings.

Algorithm may predict health-related quality of life in patients with urolithiasis

July 28, 2020

The machine learning algorithm incorporates readily available clinical information.

Patients undergoing post-URS stent placement more likely to visit ED

July 02, 2020

Study results show wide variation in stent placement following ureteroscopy.

Enzyme lowers urine oxalate levels in patients with enteric hyperoxaluria

June 17, 2020

Study results show a significant reduction in 24-hour urine oxalate in treated patients.

SuperPulsed thulium fiber laser shows several advantages

April 13, 2020

U.S. academic centers using the Soltive SuperPulsed Laser System to treat stones are finding it offers several advantages compared with holmium:YAG laser lithotripsy. But more research comparing the two is needed, according to a presentation at the 2019 World Congress of Endourology in Abu Dhabi, United Arab Emirates.

Pain interference more pronounced following URS

March 11, 2020

Findings from a longitudinal cohort study provide an evidence base for counseling patients about pain and recovery following ureteroscopy for nephrolithiasis.

Most supplements for stones not backed by science

March 06, 2020

Providers should incorporate discussion of dietary supplements into patient counseling, Kevin Koo, MD, MPH, MPhil, advises.

Single-access PCNL feasible for first-line treatment of staghorn calculi

February 28, 2020

Single-access percutaneous nephrolithotomy can clear the vast majority of staghorn stones with minimal morbidity, said Tim Large, MD, at the 2019 World Congress of Endourology and SWL in Abu Dhabi.

Pharmacotherapy reduces recurrence risk for aggressive stone disease

February 28, 2020

Pharmacotherapy for reducing risk of stone recurrence is best reserved for patients with more aggressive disease who are at higher risk for another stone-related event, said Brett A. Johnson, MD, at the 2019 World Congress of Endourology and SWL in Abu Dhabi.